Table 2.
Characteristics of patients with undetectable and detectable VLa at baseline (N=945).b
| Characteristics | Patients with undetectable baseline VL | Patients with detectable baseline VL | P value | |||||
| Patients in the study, n (%) | 521 (55.1) | 424 (44.9) | .002 | |||||
| Age (years), mean (SD) | 20.8 (2.6) | 20.8 (2.5) | .71 | |||||
| Male sex, n (%) | 328 (62.9) | 296 (69.8) | .06 | |||||
| Race and ethnicity, n (%) | .03 | |||||||
|
|
Black | 355 (68.1) | 313 (73.8) |
|
||||
|
|
White | 46 (8.8) | 20 (4.7) |
|
||||
|
|
Hispanic | 26 (5.0) | 28 (6.6) |
|
||||
|
|
Other | 62 (11.9) | 41 (9.7) |
|
||||
| VL >10,000, n (%) | N/Ac | 194 (45.7) | —d | |||||
| Log10 VL if VL was detectable, mean (SD) | N/A | 3.6 (1.2) | — | |||||
| CD4 cell count, mean (SD) | 707 (274) | 512 (321) | <.001 | |||||
| CD4 count <200 or with AIDS, n (%) | 7 (1.3) | 47 (11.1) | <.001 | |||||
aVL: viral load.
bA total of 148 patients had no baseline VL measures.
cN/A: not applicable.
dStatistical testing was not performed.